Based in Burlington of Massachusetts, Cosman Medical produces a range of radiofrequency generators, electrodes and cannulae for neurosurgery and pain management in interventional anesthesiology and podiatry.

Its radiofrequency medical technology is used to treat chronic back and neck pain, including pain from facet joint dysfunction, lumbago, sciatica, nerve impingement, intervertebral disc dysfunction, sacroiliac joint dysfunction and headaches.

In addition, the technology is also used to treat postoperative pain, complex regional pain syndrome (CRPS) and reflex sympathetic dystrophy (RSD).

Boston Scientific will integrate Cosman Medical into its neuromodulation business, which provides a range of spinal cord stimulator (SCS) systems to treat patients with chronic pain and deep brain stimulation systems for the treatment of Parkinson's disease, dystonia and essential tremor.

Boston Scientific neuromodulation president and senior vice president Maulik Nanavaty said: "This acquisition is a natural extension of our current product portfolio and will help us provide physicians and patients more options to address chronic pain with non-opioid therapeutic treatments.

"The addition of the Cosman Medical product line, which is built on industry-leading technology and known for its high-quality, expands our capability to provide innovative solutions for the treatment of chronic pain."

Cosman Medical scientific director Eric Cosman said: "We are pleased to join the Boston Scientific team and help expand access to leading treatments for chronic pain.”

Boston Scientific recently launched Precision Montage MRI spinal cord stimulator (SCS) system to treat patients with chronic pain.

The company also produces Precision Spectra system that will provide broad coverage for pain with 32 contacts, as well as non-rechargeable device Precision Novi system.